- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
DHRS2 Antibody / Dehydrogenase/reductase 2 Antibody recognizes DHRS2, also called Hep27, a member of the short-chain dehydrogenase/reductase superfamily. Proteins in this family share a characteristic nucleotide-binding fold and catalyze oxidation-reduction reactions involving diverse small molecules. Their substrates can include carbonyl-containing metabolites, lipids, and other compounds, but shared family membership does not guarantee identical chemistry. DHRS2 has been studied both as an oxidoreductase and as a protein associated with cellular stress and growth-control pathways.
DHRS2 contains sequence motifs typical of short-chain dehydrogenases and reductases, including features involved in cofactor binding and catalysis. The enzyme has been associated with mitochondrial compartments, placing it in an environment where redox reactions are central to metabolic regulation. However, the identity and relative importance of its endogenous substrates remain incompletely resolved. Assigning a specific metabolic pathway to DHRS2 requires direct evidence of substrate conversion in a physiological setting, not merely demonstration that the purified protein can reduce a candidate compound.
The DHRS2 Antibody recognizes an SDR-family protein for which both catalytic activity and reported protein interactions warrant mechanistic investigation. A notable line of investigation concerns the p53 regulatory network. DHRS2 has been reported to interact with MDM2, an E3 ubiquitin ligase that promotes p53 degradation. Experimental work suggests that this interaction may influence p53 abundance and thereby affect pathways involved in cell-cycle arrest or apoptosis. These proposed signaling functions are intriguing because they connect a protein with oxidoreductase features to the control of cellular stress responses. Whether they depend on DHRS2 catalytic activity or on a separate protein-interaction function remains an important mechanistic question.
Changes in DHRS2 expression have also been reported in cancer-related studies, although their interpretation is context dependent. Increased or decreased abundance could reflect altered metabolic requirements, stress signaling, differentiation state, or combinations of these factors. Resolving the relationship between DHRS2 enzymatic activity, intracellular localization, and MDM2-associated effects would clarify whether its metabolic and regulatory roles are mechanistically linked or represent distinct properties of the same protein.
Explore related research targets in our Metabolism Antibody / Metabolism Antibodies collection.
The ideal working dilution for the DHRS2 Antibody / Dehydrogenase/reductase 2 Antibody should be established by the investigator based on assay conditions.
The DHRS2 Antibody was generated using e. coli-derived human DHRS2 recombinant protein (amino acids M1-S248).
Store the reconstituted DHRS2 Antibody at 4oC for up to one month. For long-term storage, divide into aliquots and keep at -20oC for up to six months. Avoid repeated freeze-thaw cycles.
DHRS2 antibody, Dehydrogenase/reductase SDR family member 2, mitochondrial antibody, Dehydrogenase/reductase SDR family member 2 antibody, mitochondrial antibody, dehydrogenase/reductase 2 antibody, Dicarbonyl reductase HEP27 antibody, HEP27 antibody, Protein D antibody, SDR25C1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.